Adding niacinamide to a salicylic acid spot treatment is cosmetically feasible and very commercially popular, but it introduces formulation complexity. Niacinamide is not an OTC drug active in the acne monograph, so at typical cosmetic concentrations (2%–10%), it is considered a cosmetic ingredient making cosmetic claims ("minimizes pores," "evens skin tone") while the salicylic acid carries the drug claim. This dual-function product is legal, but your label must clearly separate the Drug Facts panel (for salicylic acid) from any cosmetic marketing claims (for niacinamide). The cosmetic chemist also needs to manage the pH conflict: niacinamide performs best at pH 5.0–7.0, while salicylic acid needs pH 3.0–4.0. A well-engineered formula finds a compromise — typically around pH 4.0–4.5 — but it requires bench work to confirm both actives remain stable and active at that pH over the product's shelf life.
Benzoyl peroxide is an entirely different situation. Benzoyl peroxide is also an OTC acne drug active, governed by its own section of 21 CFR 333. Combining two OTC drug actives in a single product is called a combination product and requires both actives to appear in the Drug Facts panel under "Active Ingredients." The FDA monograph does permit some combinations, but salicylic acid plus benzoyl peroxide in a single leave-on formula is NOT an approved monograph combination. Marketing such a product would make it an unapproved new drug — a serious regulatory violation requiring either a new drug application (NDA) or removal of one active. Virtually no low-MOQ contract manufacturer will produce this combination for OTC sale without an NDA in place.
Azelaic acid is another common pairing founders ask about. Azelaic acid is not an OTC drug active in the US (it's prescription in some concentrations); at cosmetic concentrations, it can be combined with salicylic acid without triggering the combination-OTC-drug concern, but your label claims must not imply both are drug actives.
Encapsulated actives — encapsulated retinol, time-released vitamin C, encapsulated salicylic acid itself — are increasingly popular for premium positioning. Encapsulation technology can sometimes help navigate pH conflicts because the active is released at skin surface rather than in the bulk formula. These systems add $0.30–$1.50 per unit to formulation cost and require your chemist to have experience with the specific encapsulation format.
Before greenlighting any multi-active formula, have a regulatory consultant review your complete ingredient list and intended claims. AJ Cosmo Labs connects you with formulators who specialize in complex OTC and cosmetic hybrid products so you're not discovering these constraints after you've already paid a development fee.
Ingredients in this answer: Salicylic Acid · Niacinamide · Azelaic Acid · Retinol
Read the full guide on Private Label Salicylic Acid Spot Treatment Manufacturer Low MOQ →